Monthly ArchiveMarch 2019

Boeing 737 Max Software Fix And Report On Fatal Crash Expected This Week

admin no comments

Authorities in Ethiopia are preparing prepare to release preliminary findings on the cause of the crash of an Ethiopian Airlines Boeing 737 MAX 8 jet that killed all 157 people on board. …

April 26, 2019: Antimicrobial Drugs Advisory Committee Meeting Announcement

admin no comments

April 26, 2019: Antimicrobial Drugs Advisory Committee Meeting Announcement …

April 25, 2019: Antimicrobial Drugs Advisory Committee Meeting Announcement

admin no comments

April 25, 2019: Antimicrobial Drugs Advisory Committee Meeting Announcement …

May 8, 2019: Meeting of the Pulmonary-Allergy Drugs Advisory Committee Meeting Announcement

admin no comments

May 8, 2019: Meeting of the Pulmonary-Allergy Drugs Advisory Committee Meeting Announcement …

Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present

admin no comments

The following are the medical, statistical, and clinical pharmacology reviews of pediatric studies conducted in response to a Written Request issued under the BPCA and pediatric assessments conducted under PREA. …

Written Requests Issued

admin no comments

Updated list of approved active moieties to which FDA has issued a Written Request for pediatric studies …

Pediatric Exclusivity Statistics

admin no comments

Pediatric Exclusivity Statistics updated list. …

The Midwest Battles Historic Floods In The Aftermath Of ‘Bomb Cyclone’

admin no comments

A powerful weather system swept through the region last week, bringing blizzard conditions and leaving many communities with record-setting floods. …

Bay Area’s High Cost Of Living Squeezes Restaurant Workers, Chefs And Owners

admin no comments

The San Francisco Bay Area is known for its love of fine food. It’s also increasingly becoming known as an area where it’s almost impossible to live on a service-industry wage. …

Estudio de seguridad revela el riesgo de coágulos de sangre en los pulmones y muerte con una dosis más alta de tofacitinib (Xeljanz, Xeljanz XR) en pacientes con artritis reumatoide; la FDA investigará

admin no comments

Estudio de seguridad revela el riesgo de coágulos de sangre en los pulmones y muerte con una dosis más alta de tofacitinib (Xeljanz, Xeljanz XR) en pacientes con artritis reumatoide; la FDA investigará …

Skip to toolbar